Toggle navigation
Home
Pulse
Channels
CME
Profile
Home
Pulse
Channels
CME
Profile
Nathan Delafield MD's Talks
Nathan Delafield MD
Internal Medicine Physician
SURMOUNT-1: Tirzepatide Prevents T2DM
June 28, 2026
Nathan Delafield MD
Internal Medicine Physician
00:00
--:--
SOUL Trial: Oral Semaglutide CV Benefit
June 28, 2026
Share
SOUL Trial: Oral Semaglutide CV Benefit
https://www.medspoke.co/channel_playlist?object_id=804&tap_id=12777
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Nathan Delafield MD
Internal Medicine Physician
Secondary Hyperparathyroidism Issues
May 23, 2026
Why are you reporting this TALK?
